Jorge S. Reis‐Filho

Author

Jorge S. Reis‐Filho

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

Benjamin J. Raphael, Eli Pikarsky, Guido Reifenberger, J REISFILHO, J Reis-Filho, J Reis‐Filho, J S Reis-Filho, J S Reis‐Filho, J. Reis-Filho, J. S. Reis-Filho

1.5K

Publications

94.5K

Citations

153

H-Index

177

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Institute of Cancer Research Breast Cancer Now Cornell University Breast Cancer Research Foundation

About

Jorge S. Reis‐Filho is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, tumor biology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	82	191	30.7K
2	Engineering	19	23	4K
3	Health Sciences	18	22	3.6K
4	Natural Sciences	5	5	1.2K
5	Public Health	2	2	544

Jorge S. Reis‐Filho

455

Publications

62.7K

Citations

131

H-Index

Page 1

	Year	Citations
Pan-cancer analysis of whole genomes Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse, Nature	2020	3.1K
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 Roberto Salgado, Carsten Denkert, Sandra Demaria, Annals of Oncology Lymphoid NeoplasiaBreast OncologyCancer ImmunosurveillanceMedicineImmunology	2014	3K
The landscape of cancer genes and mutational processes in breast cancer Philip J. Stephens, Patrick Tarpey, Helen Davies, Nature Breast OncologyEngineeringSomatic VariantTumor HeterogeneityCancer Genes	2012	1.7K
Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF Sonja J. Heidorn, Carla Milagre, Steven R. Whittaker, Cell	2010	1.5K
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer Isaac García-Murillas, Gaia Schiavon, Britta Weigelt, Science Translational Medicine Breast OncologyCancer PathologyPathologyTumor BiologyOncology	2015	1.1K
<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors Fei Su, Amaya Virós, Carla Milagre, New England Journal of Medicine	2012	1K
Resistance to therapy caused by intragenic deletion in BRCA2 Stacey L. Edwards, Rachel Brough, Christopher J. Lord, Nature Intragenic DeletionOncogenic AgentPathologyCancer GeneticsMedicine	2008	979
The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers Pedram Razavi, Matthew T. Chang, Guotai Xu, Cancer Cell Breast OncologyGenomic LandscapeCancer GenomicsBreast CancerRadiation Oncology	2018	956
Complex landscapes of somatic rearrangement in human breast cancer genomes Philip J. Stephens, David J. McBride, Meng‐Lay Lin, Nature ChromatinComplex LandscapesSomatic VariantTumor HeterogeneityNatural Sciences	2009	838
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma Leticia De Mattos‐Arruda, Regina Mayor, Charlotte K.Y. Ng, Nature Communications Plasma CtdnaPathologyHigh-grade GliomasGliomaTumor Biology	2015	822

Page 1